[1] 中国疾病预防控制中心 性病艾滋病预防控制中心 性病控制中心.2017年12月全国艾滋病性病疫情[J].中国艾滋病性病,2018,24(2):111.
[2] 中华人民共和国国家卫生健康委员会. 2017年全国法定传染病疫情概况[EB/OL].[2018-02-26].http://www.nhc.gov.cn/jkj/s3578/201802/de926bdb046749abb7b0a8e23d929104.shtml.
[3] U.S. Department of Health and Human Services. Antiretroviral drugs used in the treatment of HIV infection[EB/OL].[2018-4-12]. https://www.fda.gov/ForPatients/Illness/HIVAIDS/Treatment/ucm118915.htm.
[4] World Health Organization, United States Centers for Disease Control and Prevention, The Global Fund to Fight AIDS, Tuberculosis and Malaria. HIV drug resistance report 2017[EB/OL].[2017-07]. http://who.int/hiv/pub/drugresistance/hivdr-report-2017/en/.
[5] Hong SY, Jonas A, Deklerk M, et al. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia[J]. J Acquir Immune Defic Syndr, 2015, 68(4):463-471.
[6] Xing H,Ruan Y,Li J,et al.HIV drug resistance and its impact on antiretrovirat therapy in Chinese HIV—infected patients[J].PLoSOne,2013, 8(2):e54917.
[7] Xing H,Ruan Y,Hsi JH,et al.Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.[J]. Journal of Antimicrobial Chemotherapy, 2015, 70(7):2097-2013.
[8] Lin B, Sun X, Su S, et al. HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China[J]. Plos One, 2017, 12(7):e0181997.
[9] 曹慜,杨东智,吴忠兰,等.宁夏抗病毒治疗患者HIV基因型耐药及亚型分析[J].现代预防医学,2018,45(1):149-154.
[10] 卢静,周莹,徐晓琴,等.江苏省抗病毒治疗失败HIV/AIDS患者耐药情况及基因型分析[J].江苏预防医学,2016,27(4):388-391.
[11] 肖培培, 卢静, 胡海洋,等. 2016年江苏省579例艾滋病抗病毒治疗失败患者HIV-1耐药突变状况及影响因素分析[J]. 中华预防医学杂志, 2017,51(11):988-993.
[12] 温兰, 杨晓辉, 沈月兰. 阜阳市HIV抗病毒治疗患者耐药情况分析[J]. 安徽预防医学杂志, 2018(3):179-183.
[13] Liao L, Xing H, Su B, et al. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China[J]. Aids, 2013, 27(11):1815-1824.
[14] 钟敏,李韩平,李惠琴,等.云南省2012年人类免疫缺陷病毒感染者和艾滋病患者抗病毒治疗失败基因型耐药情况分析[J].中华传染病杂志,2015,33(1):30-33.
[15] 王征桦,吴守丽,张春阳,等. 2008-2013年福建省HIV-1毒株耐药基因变异研究[J]. 中国人兽共患病学报,2015,31(4):330-333,344.
[16] 周凤岩,李扬,左中宝,等.吉林市HIV-1感染者基因型耐药分析及亚型分布[J].中国生物制品学杂志,2016,29(7):733-736.
[17] 兰芸,蔡卫平,李凌华,等.2015年广东省抗病毒治疗失败艾滋病患者非核苷类逆转录酶抑制剂耐药相关基因突变分析[J].中华临床感染病杂志,2017,10(1):14-19.
[18] 刘佳,闫江舟,杨文杰,等.河南省1922例艾滋病一线抗病毒治疗失败患者中HIV耐药基因突变情况分析[J].中华预防医学杂志,2015,49(11):950-955.
[19] 袁丹,叶黎,龚芳红,等.2014年四川省部分地区HIV/AIDS患者抗病毒治疗效果和耐药性影响因素分析[J].现代预防医学,2016,43(13):2445-2452.
[20] 鄂爽,吴少慧,马宁,等.辽宁省2004-2011年抗病毒治疗人群HIV-1亚型分布及耐药分析[J].中国艾滋病性病,2013,19(8):606-607.
[21] Rhee SY, Jordan MR, Raizes E, et al. HIV-1 drug resistance mutations:potential applications for point-of-care genotypic resistance testing[J].PLoS One,2015, 10(12):e0145772. doi: 10.1371/journal.pone.0145772. eCollection 2015.
[22] Schmidt D, Kollan C, Fätkenheuer G, et al. Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany[J]. Plos One, 2014, 9(8):e104474.
[23] 耿庆茂,李韩平,辛天义,等.对in-house HIV-1基因型耐药性检测方法的评价[J].中华检验医学杂志,2011,34(9):849-854.
[24] 李晶,蒋岩,吕超,等.三种HIV-1基因型耐药检测方法的一致性评价[J].中华预防医学杂志,2013,47(11):1050-1055.
[25] Chimukangara B, Varyani B, Shamu T, et al. HIV drug resistance testing among patients failing second line antiretroviral therapy-Comparison of in-house and commercial sequencing.[J]. Journal of Virological Methods, 2016, 243:151-157.
[26] Group TRS.Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study[J]. Lancet Infectious Diseases, 2016, 16(5):565.
[27] Luca AD,Sidumo ZJ,Zanelli G,et al.Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique[J]. Bmc Infectious Diseases, 2017, 17(1):605.
[28] UNAIDS.90-90-90:An ambitious treatment target to help end the AIDS epidemic.[R]. Geneva Switzerland:Unaids Joint United Nations Programme on Hiv/AIDS,2014.